Speakers

Aadarash Zia

Senior Scientist - Drug Delivery

Medicines Discovery Catapult

Adrian Lopez

Partner

Discovery Ventures

Mr Alan Whitmore

Chief Scientific Officer

Tangram Therapeutics

Alejandro Mahía Moros

Senior Researcher

Certest

Arun Kumar

RNA Innovations Programs Leader

CEPI

Bo Ying

CEO

Abogen Biosciences

Bo Rode Hansen, Ph.D.

Executive Chair

Heqet Therapeutics

Bogdan Rivoal

CEO

NeXendia

Cesar Lopez-Camacho

Group Leader

University Of Oxford

Christophe Bonneville, PhD

CEO & Co-Founder

Dillico

Daniel Blessing

CTO

HAYA Therapeutics

David Entwistle

Sr Director, Program & Pipeline Management, Pharma Manufacturing

Codexis

David Hardwicke

Co-Founder

Aerska

Dee Datta

Co-founder & CEO

Switch Therapeutics

Diego Piqueras-Losilla

Research Scientist

ARTHEx Biotech

Dominik Witzigmann

Co-founder and President

Nanovation Therapeutics

Elisa Kulterer

Researcher

University of Vienna

Emily Young

Director of Scientific Applications

4Basebio

Felix Schumacher

Mission Lead RNAHub

Roche

Hagen Cramer, PhD

Chief Technology Officer

QurAlis

Dr Hani Najafi

Assistant Professor of Cell and Developmental Biology

Cornell University

Hans Huber

CEO

Biomay

Ivan Burkov

Partner

INKEF Capital

Jacob Borrajo

CEO

Amber Bio

Jade Osei-Tutu

Head of RNA Leaders

Informa Connect

Jeff Raphael

Founder & Managing Partner

OmniScope Partners

Ms Jenny van Asbeck-van der Wijst

CEO

Mercurna

John Taylor

Global Head of Business Development

Ribocure

Jun Zhou

Senior Director, Oligonucleotide Medicinal Chemistry

WuXi TIDES

Kaido Kurrikoff

CEO

Vectiopep

Karina Thorn

Vice President, Head of Nucleic Acid Research

Novo Nordisk

Lorna Harries

CSO

ISCARNA

Lydia Kalafateli

Investment Manager

BOM

Maj Petersen, PhD

Senior Director of Innovation and Project Execution

Novo Nordisk

Marie Wikstrom-Lindholm

CSO

Silence Therapeutics

Mr Mark Dickman

Professor

University of Sheffield

Matthias Hackl

CEO

TAmiRNA

Michael Khan

CEO

ARGONAUTE RNA LIMITED

Michael Wolfinger

Principal Investigator

University of Vienna

Michal Karlubik

Head of Partnerships & External Affairs

Sensible Biotechnologies

Michelle Lynn Hall

General Partner

Entrée Capital

Mina Zion

Director

Weill Cornell Medicine

Nathaniel Wang, PhD

CEO

Replicate Bioscience

Neal Millar

CMO

Causeway Therapeutics

Nick Lench

Executive Director

Nucleic Acid Therapy Accelerator

Nicola Guzzi

Associate Principal Scientist

AstraZeneca

Nicole Moschny

Investment Manger

HTGF

Ms Paola Pozzi

Partner, Sofinnova Telethon Fund

Sofinnova Partners

Paul Nioi, PhD

SVP

Alnylam Pharmaceuticals, Inc.

Dr. Peter Weinstein

Chief Executive Officer

Circurna

Philipp Schreppel

Senior Director Business Development

Ethris

Philippe Vollmer Barbosa

Project Manager

Fraunhofer

Poul Sørensen

CEO

Inverna therapeutics

Renee Williams

Founder & Managing Partner

Williams Biotech Consulting

Rok Sekirnik

Head Process Development mRNA/pDNA

Sartorius BIA Separations

Sabine Fenner

Director Oligo R&D

bachem

Siham Ceballos

Managing Partner

BioArtemis

Sonia Hallen

Investment Manager

Gilde Healthcare

Dr. Sonja Merkas, PhD

Founder, Creator and Doer

Livinovea

Sophia Lugo

CEO

Radar Therapeutics

Sophie Hammer

Senior Manager Strategic & Technical Marketing

Evonik

Steffen Schubert

Vice President- Drug Discovery

Silence Therapeutics

Steve Pascolo

Researcher (Former Founder, CureVac)

University Hospital of Zurich

Sudhir Agrawal

President and Founder

Arnay Sciences

Tero-Pekka Alastalo

CEO & Founder

Avenue Biosciences

Victor Levitsky

CSO

Circio

Víctor R. de la Rosa

Commercial Product Manager

CURAPATH

Xuecheng Jiao, Ph.D

Vice General Manager

Asymchem Labs